Status:
UNKNOWN
Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
Lead Sponsor:
Medical University of Lodz
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
CHD - Coronary Heart Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aim is to assess polyethylene glycol (PEG) coated collagen patch (Hemopatch) on the quality of drainage after surgery, the length of hospital stay, the number of reoperations due to haemorrh...
Eligibility Criteria
Inclusion
- coronary heart disease CHD (mammary harvesting)
- age\>18
- informed consent
Exclusion
- any condition that exclude patient from standard CABG procedure
- additional cardiac procedure to be conducted on subject in addition to CABG
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03340090
Start Date
March 20 2018
End Date
December 31 2019
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Lodz
Lodz, Łódź Voivodeship, Poland